|
Imaging features
|
Sensitivity (95% CI)
|
Specificity (95% CI)
|
PPV (95% CI)
|
NPV (95% CI)
|
Az value (95% CI)
|
|---|
|
Body/tail location
|
83.8% (65.5–93.9%)
|
47.4% (31.3–64.0%)
|
56.5% (41.2–70.8%)
|
78.3% (55.8–91.7%)
|
0.656 (52.7–78.6%)
|
|
Round shape
|
77.4% (58.5–89.7%)
|
73.7% (56.6–86.0%)
|
70.6% (52.3–84.3%)
|
80.0% (62.5–90.9%)
|
0.756 (63.7–87.4%)
|
|
Thick wall
|
67.7% (48.5–82.7%)
|
76.3% (59.4–88.0%)
|
70.0% (50.4–84.6%)
|
74.4% (57.6–86.4%)
|
0.720 (59.6–84.5%)
|
|
0–2 septa
|
64.5% (45.4–80.2%)
|
71.1% (53.9–84.0%)
|
64.5% (45.4–80.2%)
|
71.1% (53.9–84.0%)
|
0.678 (54.9–80.7%)
|
|
Two features
|
90.3% (73.1–97.4%)
|
60.5% (43.5–75.5%)
|
65.1% (49.0–78.5%)
|
88.5% (68.7–97.0%)
|
0.754 (63.8–87.1%)
|
|
Three features
|
77.4% (58.5–89.7%)
|
84.2% (68.1–93.4%)
|
80.0% (60.8–91.6%)
|
82.1% (65.9–91.9%)
|
0.808 (69.6–91.7%)
|
|
Four features
|
25.8% (12.5–44.9%)
|
92.1% (77.5–97.9%)
|
72.7% (39.3–92.7%)
|
60.3% (46.6–72.7%)
|
0.590 (45.2–72.7%)
|
- MCNs mucinous cystic neoplasms, PPV positive predictive value, NPV negative predictive value, CI confidence interval
